debromohymenialdisine and Inflammation

debromohymenialdisine has been researched along with Inflammation* in 1 studies

Other Studies

1 other study(ies) available for debromohymenialdisine and Inflammation

Article	Year
(10 Molecules (Basel, Switzerland), 2019, Sep-18, Volume: 24, Issue:18 Crohn's disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel disease (IBD), are autoimmune diseases characterized by chronic inflammation within the gastrointestinal tract. Debromohymenialdisine is an active pyrrole alkaloid that is well known to serve as a stable and effective inhibitor of Chk2. In the present study, we attempted to investigate the anti-inflammatory properties of (10 Topics: Animals; Aquatic Organisms; Azepines; Caco-2 Cells; Coculture Techniques; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Intestines; Porifera; Pyrroles; THP-1 Cells	2019

Article

Year

Molecules (Basel, Switzerland), 2019, Sep-18, Volume: 24, Issue:18

Crohn's disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel disease (IBD), are autoimmune diseases characterized by chronic inflammation within the gastrointestinal tract. Debromohymenialdisine is an active pyrrole alkaloid that is well known to serve as a stable and effective inhibitor of Chk2. In the present study, we attempted to investigate the anti-inflammatory properties of (10

Topics: Animals; Aquatic Organisms; Azepines; Caco-2 Cells; Coculture Techniques; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Intestines; Porifera; Pyrroles; THP-1 Cells

2019